Get the latest Science News and Discoveries

Smart jab can shrink head and neck cancer tumours within six weeks, trial finds. Triple-action therapy drug amivantamab could be given as an injection to help treat recurrent or metastatic cancers.

Triple-action therapy drug amivantamab could be given as an injection to help treat recurrent or metastatic cancers

None

Get the Android app